34 related articles for article (PubMed ID: 38614071)
1. Preoperative single-dose camrelizumab and/or microwave ablation in women with early-stage breast cancer: A window-of-opportunity trial.
Pan H; Yu M; Tang X; Mao X; Liu M; Zhang K; Qian C; Wang J; Xie H; Qiu W; Ding Q; Wang S; Zhou W
Med; 2024 Apr; 5(4):291-310.e5. PubMed ID: 38417440
[TBL] [Abstract][Full Text] [Related]
2. Camrelizumab combined with microwave ablation improves the objective response rate in advanced non-small cell lung cancer.
Wei Z; Yang X; Ye X; Huang G; Li W; Han X; Wang J; Meng M; Ni Y; Zou Z; Wen Q
J Cancer Res Ther; 2019; 15(7):1629-1634. PubMed ID: 31939448
[TBL] [Abstract][Full Text] [Related]
3. Rechallenge of camrelizumab in non-small-cell lung cancer patients treated previously with camrelizumab and microwave ablation.
Wei Z; Yang X; Ye X
J Cancer Res Ther; 2020 Sep; 16(5):1191-1195. PubMed ID: 33004770
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: A pre-clinical study in a murine model.
Zhu J; Yu M; Chen L; Kong P; Li L; Ma G; Ge H; Cui Y; Li Z; Pan H; Xie H; Zhou W; Wang S
Diagn Interv Imaging; 2018 Mar; 99(3):135-142. PubMed ID: 29398572
[TBL] [Abstract][Full Text] [Related]
5. Landscape of the Peripheral Immune Response Induced by Local Microwave Ablation in Patients with Breast Cancer.
Zhou W; Yu M; Mao X; Pan H; Tang X; Wang J; Che N; Xie H; Ling L; Zhao Y; Liu X; Wang C; Zhang K; Qiu W; Ding Q; Wang S
Adv Sci (Weinh); 2022 Jun; 9(17):e2200033. PubMed ID: 35403824
[TBL] [Abstract][Full Text] [Related]
6. Thermo-immune synergy: Camrelizumab plus microwave ablation in preoperative early-stage breast cancer.
Xiao YL; Wu SY; Jiang YZ
Med; 2024 Apr; 5(4):278-280. PubMed ID: 38614071
[TBL] [Abstract][Full Text] [Related]
7. Tissue-resident memory T cells in breast cancer control and immunotherapy responses.
Byrne A; Savas P; Sant S; Li R; Virassamy B; Luen SJ; Beavis PA; Mackay LK; Neeson PJ; Loi S
Nat Rev Clin Oncol; 2020 Jun; 17(6):341-348. PubMed ID: 32112054
[TBL] [Abstract][Full Text] [Related]
8. Microwave ablation for liver tumors.
Dou JP; Liang P; Yu J
Abdom Radiol (NY); 2016 Apr; 41(4):650-8. PubMed ID: 26880177
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Ablation-Induced Immunomodulation in Hepatocellular Carcinoma.
Dumolard L; Ghelfi J; Roth G; Decaens T; Macek Jilkova Z
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575734
[TBL] [Abstract][Full Text] [Related]
10. Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?
Gerber HP; Sapra P; Loganzo F; May C
Biochem Pharmacol; 2016 Feb; 102():1-6. PubMed ID: 26686577
[TBL] [Abstract][Full Text] [Related]
11. The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer.
Naik A; Monjazeb AM; Decock J
Front Immunol; 2019; 10():1940. PubMed ID: 31475003
[TBL] [Abstract][Full Text] [Related]
12. Salvage camrelizumab plus apatinib for relapsed esophageal neuroendocrine carcinoma after esophagectomy: a case report and review of the literature.
Liu L; Liu Y; Gong L; Zhang M; Wu W
Cancer Biol Ther; 2020 Nov; 21(11):983-989. PubMed ID: 33092443
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
